Ablation of p38α MAPK Signaling in Osteoblast Lineage Cells Protects Mice From Bone Loss Induced by Estrogen Deficiency
- PMID: 26441240
- DOI: 10.1210/en.2015-1669
Ablation of p38α MAPK Signaling in Osteoblast Lineage Cells Protects Mice From Bone Loss Induced by Estrogen Deficiency
Abstract
Estrogen deficiency causes bone loss by increasing the number of bone-resorbing osteoclasts. Selective p38α MAPK inhibitors prevent bone-wasting effects of estrogen withdrawal but implicated mechanisms remain to be identified. Here, we show that inactivation of the p38α-encoding gene in osteoblast lineage cells with the use of an osteocalcin-cre transgene protects mice from ovariectomy-induced bone loss (a murine model of postmenopausal osteoporosis). Ovariectomy fails to induce bone loss, increase bone resorption, and stimulate receptor activator of nuclear factor κB ligand and IL-6 expression in mice lacking p38α in osteoblasts and osteocytes. Finally, TNFα or IL-1, which are osteoclastogenic cytokines overproduced in the bone marrow under estrogen deficiency, can activate p38α signaling in osteoblasts, but those cytokines cannot enhance Rankl and Il6 expressions or increase osteoclast formation in p38a-deficient osteoblast cultures. These findings demonstrate that p38α MAPK signaling in osteoblast lineage cells mediates ovariectomy-induced bone loss by up-regulating receptor activator of nuclear factor κB ligand and IL-6 production.
Similar articles
-
The TRPV1 ion channel antagonist capsazepine inhibits osteoclast and osteoblast differentiation in vitro and ovariectomy induced bone loss in vivo.Bone. 2010 Apr;46(4):1089-99. doi: 10.1016/j.bone.2010.01.368. Epub 2010 Jan 22. Bone. 2010. PMID: 20096813
-
Lipopolysaccharide-mediated enhancement of bone metabolism in estrogen-deficient mice.J Periodontol. 2008 Nov;79(11):2173-81. doi: 10.1902/jop.2008.070127. J Periodontol. 2008. PMID: 18980527
-
p38α MAPK Regulates Lineage Commitment and OPG Synthesis of Bone Marrow Stromal Cells to Prevent Bone Loss under Physiological and Pathological Conditions.Stem Cell Reports. 2016 Apr 12;6(4):566-578. doi: 10.1016/j.stemcr.2016.02.001. Epub 2016 Mar 3. Stem Cell Reports. 2016. PMID: 26947973 Free PMC article.
-
Cellular and molecular effects of growth hormone and estrogen on human bone cells.APMIS Suppl. 1997;71:1-30. APMIS Suppl. 1997. PMID: 9357492 Review.
-
[Cytokines in bone diseases. Cytokine and postmenopausal osteoporosis].Clin Calcium. 2010 Oct;20(10):1467-72. Clin Calcium. 2010. PMID: 20890027 Review. Japanese.
Cited by
-
Conditional deletion of E11/Podoplanin in bone protects against ovariectomy-induced increases in osteoclast formation and activity.Biosci Rep. 2020 Jan 31;40(1):BSR20190329. doi: 10.1042/BSR20190329. Biosci Rep. 2020. PMID: 31894854 Free PMC article.
-
Effects of Multi-Task Mode on Cognition and Lower Limb Function in Frail Older Adults: A Systematic Search and Review.Healthcare (Basel). 2023 Nov 21;11(23):3012. doi: 10.3390/healthcare11233012. Healthcare (Basel). 2023. PMID: 38063580 Free PMC article. Review.
-
Morin protects glucocorticoid-induced osteoporosis through regulating the mitogen-activated protein kinase signaling pathway.J Nat Med. 2018 Sep;72(4):929-936. doi: 10.1007/s11418-018-1228-4. Epub 2018 Jul 24. J Nat Med. 2018. PMID: 30043216
-
The role and regulation mechanism of Chinese traditional fitness exercises on the bone and cartilage tissue in patients with osteoporosis: A narrative review.Front Physiol. 2023 Feb 28;14:1071005. doi: 10.3389/fphys.2023.1071005. eCollection 2023. Front Physiol. 2023. PMID: 36926189 Free PMC article. Review.
-
Overexpression of miRNA-22-3p attenuates osteoporosis by targeting MAPK14.Exp Ther Med. 2021 Jul;22(1):692. doi: 10.3892/etm.2021.10124. Epub 2021 May 2. Exp Ther Med. 2021. PMID: 33986857 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
